While Basaglar can be prescribed for both type 1 and type 2 diabetes in adults and also in children aged 6+, Ozempic, however, is only approved for type 2 diabetes & isnt an option for people with type 1 diabetes TL;DR Basaglar (insulin glargine) and Ozempic (semaglutide) treat type 2 diabetes through completely different mechanisms Basaglar is a long acting basal insulin injected daily that directly replaces insulin your body lacks while Ozempic is a GLP 1 receptor agonist injected weekly that enhances your bodys natural insulin production Key differences: Ozempic promotes weight loss (10-15%) while Basaglar often causes weight gain Ozempic reduces A1C by 1.4-1.8% vs Basaglars 0.8-1.5%
Key Takeaway: Glutathione is the body's master antioxidant, but its effectiveness as a supplement depends entirely on bioavailability
Indeed, HCPs should take care to provide those patients with eating disorders who are going to start GLP-1 RA treatment with educational tips aimed at promoting a healthy lifestyle
Less water = stronger concentration
A commenter explained that CMS should not use CPT code 98975 ( ( Remote therapeutic monitoring (e.g., therapy adherence, therapy response, digital therapeutic intervention)
The original version of this story was published on HuffPost at an earlier date.
